Drug Type CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism ROR1 modulators(Inactive tyrosine-protein kinase transmembrane receptor ROR1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Discovery | China | 13 May 2024 | |
Mantle-Cell Lymphoma | Discovery | China | 13 May 2024 |